Cite

HARVARD Citation

    Sekiguchi, N. et al. (2022). Two‐year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia. Cancer science. 113 (6), pp. 2085-2096. [Online]. 
  
Back to record